CONRAD 120
Status:Completed
Phase:I
Principal Investigator(s):
Objective:To evaluate 1% tenofovir vaginal ring.
Prevention Option(s):Microbicides, MPTs
Study Design:
Arms and Assigned Interventions
Description1% tenofovir vaginal ring
Mode of DeliveryRing
ARMsExperimental
Trial Sponsors:
CONRAD
Start Date
End Date
June 30, 2012
December 31, 2012
Enrollment:36
Age range:
↔
any
Population:Cisgender Women